POST Online Media Lite Edition



 

BioNTech expects vaccine trial results for babies by September

Christian Fernsby |
BioNTech expects results by September from trials testing the COVID-19 vaccine that it and Pfizer have developed in babies as young as six months old, German magazine Spiegel cited the company’s CEO as saying.

Article continues below



Topics: BIONTECH   

“In July, the first results could be available for the five to 12 year olds, in September for the younger children,” BioNTech Chief Executive Ugur Sahin told Spiegel. He added it takes about four to six weeks to evaluate the data.

“If all goes well, as soon as the data is evaluated, we will be able to submit the application for approval of the vaccine for all children in the respective age group in different countries,” he said.


What to read next

BioNTech to acquire plant in Germany to produce coronavirus vaccine
Pfizer and BioNTech share positive early data on mRNA vaccine candidate BNT162b2 against coronavirus
Sanofi and BioNTech in multiyear exclusive agreement